相关实验视频
Updated: Sep 13, 2025

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
关于实施注册表的政策建议,以尽量减少在I期临床试验中的过度志愿者
Roberto Abadie1, Jill A Fisher2, Shadreck Mwale3
1Department of Kinesiology, School of Education, University of Wisconsin-Madison, Madison, WI, USA.
参与多项临床试验的健康志愿者可能会因过度志愿而受到伤害. 实施强制性注册对于志愿者安全和可靠的研究结果至关重要.
科学领域:
- 临床研究 临床研究
- 药物开发 药物开发
- 公共卫生 公共卫生
背景情况:
- 每年有成千上万的健康志愿者参加I期临床试验,通常是为了获得经济激励.
- 过度的志愿服务,包括同时参与或跳过洗期,对志愿者和数据完整性构成风险.
- 第一阶段试验,特别是首次在人体上进行的试验,具有固有的,不可预测的风险,这些风险可以通过未披露的多重试验参与而被放大.
研究的目的:
- 突出在I期临床试验中过度志愿服务的风险.
- 检查当前临床试验登记册的情况,以对志愿者进行监督.
- 倡导广泛采用强制性登记册,以提高志愿者安全和研究可靠性.
主要方法:
- 对现有文献和案例的审查,涉及志愿者过度参与临床试验.
- 分析目前在不同国家实施的国家和私人注册系统.
- 讨论实施强制性临床试验注册表的障碍和促进因素.
主要成果:
- 虽然一些国家和私人实体使用注册表,但追踪临床试验招生的强制性系统并未被普遍采用.
- 过度志愿服务可能会导致不良事件的增加和受损的试验数据,由于潜在的药物相互作用.
- 现有的注册表在范围和强制执行方面各不相同,许多国家缺乏全面的监督.
结论:
- 广泛采用强制性临床试验注册表对于保护健康志愿者免受潜在伤害至关重要.
- 注册表提高了临床试验结果的透明度,可靠性和完整性.
- 实施强大的注册系统对于开发更安全,更有效的药物至关重要.
更多相关视频
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
相关概念视频
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Ethics in Research